RedHill Biopharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 189.2%.

Top 25 shareholders own 8.3% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
5.47%	Heights Capital Management, Inc.	70,000	US$479.5k	0%	0.21%
2.02%	Empery Asset Management, LP	25,913	US$177.5k	0%	14.9%
0.31%	Fédération des Caisses Desjardins du Québec, Asset Management Arm	3,992	US$27.3k	-0.08%	no data
0.12%	Virtu Financial LLC, Asset Management Arm	1,484	US$10.2k	0%	no data
0.076%	Rhumbline Advisers Ltd Partnership	979	US$6.7k	29.3%	no data
0.061%	Kenneth Reed	780	US$5.3k	0%	no data
0.041%	Shmuel Cabilly	520	US$3.6k	0%	no data
0.031%	Osaic Wealth, Inc. , Asset Management Arm	396	US$2.7k	0%	no data
0.031%	Dror Ben-Asher	391	US$2.7k	0%	no data
0.021%	Adi Frish	265	US$1.8k	0%	no data
0.019%	Gilead Raday	244	US$1.7k	0%	no data
0.015%	R & S United Services, Inc.	187	US$1.3k	0%	no data
0.014%	Reza Fathi	180	US$1.2k	0%	no data
0.014%	Morgan Stanley, Investment Banking and Brokerage Investments	180	US$1.2k	1,190%	no data
0.013%	Razi Ingber	167	US$1.1k	0%	no data
0.013%	Guy Goldberg	164	US$1.1k	0%	no data
0.01%	Avi Polischuk	132	US$904.4	0%	no data
0.0095%	Eric Swenden	122	US$835.9	0%	no data
0.0089%	Rick Scruggs	114	US$780.7	0%	no data
0.0032%	Geode Capital Management, LLC	41	US$280.7	0%	no data
0.0017%	Group One Trading LP, Asset Management Arm	22	US$150.9	-8.33%	no data
0.0013%	Alla Felder	16	US$109.6	0%	no data
0.0013%	Regina Polischuk	16	US$109.6	0%	no data
0.0012%	Ofer Tsimchi	15	US$102.6	0%	no data
0.0011%	Yorkville Asset Management Inc.	14	US$95.6	0%	no data